Loophole exposed in testing of child medicinesBMJ 1997; 314 doi: https://doi.org/10.1136/bmj.314.7082.695i (Published 08 March 1997) Cite this as: BMJ 1997;314:695
- John Warden, parliamentary correspondent
Numerous gaps in the health care of children and young people in Britain-notably in the testing of child medicines-have been identified by the House of Commons Health Committee.
In the first two reports the MPs state that the special needs of children are given insufficient priority by policymakers and health service professionals. A main finding is that medicines for children are not controlled in the same way as for adults. Some medicines given to children are not licensed for human administration at all, …
Log in using your username and password
Log in through your institution
Sign up for a free trial